Secretion of MUC5AC mucin from pancreatic cancer cells in response to forskolin and VIP

Biochemical and Biophysical Research Communications

Volumn 294, Issue 3, 2002, Pages 680-686

  Ho, Jenny J L ^a   Crawley, Suzanne ^a   Pan, Pamela L ^a   Farrelly, Ellyn R ^a   Kim, Young S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cAMP; Cancer; Forskolin; MUC5AC; Pancreas; VIP

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; MUCIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER CELL CULTURE; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; TISSUE CULTURE;

FORSKOLIN; GASTROINTESTINAL AGENTS; HUMANS; MUCINS; PANCREATIC NEOPLASMS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036289094     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00529-6     Document Type: Article

References (20)

1. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines
2. Mucin 5AC is upregulated in pancreatic tumors
3. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma
4. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors
5. Immunohistological characterization of mucin epitopes by pre-treatment of gastro-intestinal sections with periodic acid
6. Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis is encoded by the MUC5AC gene
7. Immunohistochemical study of MUC5AC expression human gastric carcinomas using a novel monoclonal antibody
8. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin
9. Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice
10. Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors
11. Forskolin increases the expression of the pancreatic tumor antigen, Nd2, and uptake of Nd2 antibody
12. Expression of mucin-associated tumor antigens is altered by cell density
13. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line
14. Preoperative clinical adioimmunodetection of pancreatic cancer by 111In-labeled chimeric monoclonal antibody Nd2
15. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice
16. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells
17. Targeting of epidermal growth factor receptor and protein kinase A: Molecular basis and therapeutic applications
18. Role of growth factors in pancreatic cancer
19. EGF enhances the effect of vasoactive intestinal hormone in elevating the level of the pancreatic tumor antigen Nd2